2023
7 June, 2023
FluoGuide announces positive topline results from phase IIa trial of FG001 in lung cancer
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery...
Copenhagen, Denmark, 31 May 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) today releases its results...
FluoGuide A/S (“FluoGuide” or the “Company”), a Danish biotech company that pioneers precision cancer surgery...
FluoGuide A/S (“FluoGuide” or the “Company”) is pleased to announce that Innovation Fund Denmark (Innovationsfonden)...
21 March, 2023
Minutes from Annual General Meeting in FluoGuide A/S
Copenhagen, Denmark, 21 March 2023 – FluoGuide A/S (“FluoGuide” or the “Company”) held its annual general...
6 March, 2023
Notice of Annual General Meeting in FluoGuide A/S
The board of directors hereby convenes the Annual General Meeting of FluoGuide A/S, company registration (CVR) no. 39 29 64 38 (the...
27 February, 2023
FluoGuide updates on recruitment in phase IIb aggressive brain cancer trial with FG001
FluoGuide A/S (“FluoGuide” or the “Company”) provides an update on the clinical timelines for the ongoing clinical...
2 February, 2023
FluoGuide appoints Ole Larsen as CFO
FluoGuide A/S (“FluoGuide” or the “Company”) has appointed Ole Larsen as Chief Financial Officer (“CFO”)...
